These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8229608)

  • 1. Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice.
    Ergaz Z; Arad I
    J Perinat Med; 1993; 21(3):183-7. PubMed ID: 8229608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin.
    Ergaz Z; Gross D; Bar-Oz B; Peleg O; Arad I
    Vox Sang; 1995; 69(2):95-9. PubMed ID: 8585207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
    Elalfy MS; Elbarbary NS; Abaza HW
    Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.
    Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U
    Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
    Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
    Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
    Li ZH; Wang J; Chen C
    Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulins in rhesus hemolytic disease.
    Mukhopadhyay K; Murki S; Narang A; Dutta S
    Indian J Pediatr; 2003 Sep; 70(9):697-9. PubMed ID: 14620183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
    Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
    J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin for hemolytic jaundice in Japan: A retrospective survey.
    Ono H; Kakiuchi S; Kusuda S
    Pediatr Int; 2023; 65(1):e15702. PubMed ID: 38037498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease.
    Dağoğlu T; Ovali F; Samanci N; Bengisu E
    J Int Med Res; 1995; 23(4):264-71. PubMed ID: 7589769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
    Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
    Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy for hyperbilirubinemia caused by Rhesus hemolytic disease.
    Merchant RH; Pradeep S
    Indian Pediatr; 1994 Oct; 31(10):1269-71. PubMed ID: 7875791
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis?
    Hammerman C; Vreman HJ; Kaplan M; Stevenson DK
    Acta Paediatr; 1996 Nov; 85(11):1351-3. PubMed ID: 8955465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of single versus double volume exchange transfusion in newborn infants with AB0 hemolytic disease.
    Amato M; Blumberg A; Hermann U; Zurbrügg R
    Helv Paediatr Acta; 1988 Nov; 43(3):177-86. PubMed ID: 3220789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.